Delivery Order SPE2DB25D3404-SPE2DB25FUMGE
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$35K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,858.85 firm fixed-price contract is for the delivery of emtricitabine-tenofovir 200-300mg pharmaceutical products. The contract has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,689.89, is for the delivery of emtricitabine-tenofovir 200-300 mg medication, with a final completion date of February 27, 2025. The contract is a firm fixed-price delivery order, without any set-aside requirements. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,923.81, is for the delivery of emtricitabine-tenofovir 200-300 mg prescription medications. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Emtricitabine-Tenofovir 200-300 mg medication. The $5,104.14 firm-fixed-price contract has a completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,453.35, is for the delivery of emtricitabine-tenofovir 200-300 mg medications. The contract is a delivery order and has a firm fixed price pricing type, with a completion date of December 30, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,350.48, is for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,472.40, is for the delivery of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract is a firm fixed price delivery order with a completion date of February 23, 2024. No set-aside designation was used for this award....
This delivery order contract, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 4,561,773,544 units of the HIV medication emtricitabine-tenofovir 200-300 mg. The $1,872.24 firm fixed price award has an ultimate completion date of August 11, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.08 firm fixed-price delivery order contract is for the supply of 4563354076 emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of January 19, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...